Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3, Prospective, Randomized, Multicenter, Single-blind, Controlled Study Evaluating Arteriovenous Fistula Outcomes With and Without a Perivascular Sirolimus Eluting Collagen Implant (The ACCESS 2 Trial)

NCT05425056 is registered in ClinicalTrials.gov with Vascular Therapies, Inc. as lead sponsor.

NCT NCT05425056
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05425056 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3, Prospective, Randomized, Multicenter, Single-blind, Controlled Study Evaluating Arteriovenous Fistula Outcomes With and Without a Perivascular Sirolimus Eluting Collagen Implant (The ACCESS 2 Trial)
Lead sponsor
Vascular Therapies, Inc.
Phase
Phase 3
Overall status
Completed
Start date
August 26, 2022
Completion date
August 29, 2025
Enrollment
136 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

arteriovenous fistula, chronic kidney failure, complication of hemodialysis, complication of renal dialysis, end stage kidney disease, end stage renal disease, esrd, vascular access complication